Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | UGT2B7 | P16662 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL813343 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL1583053 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL10971244 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL9617991 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL813344 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL813341 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL954543 | 0.86 | UGT2B7 (0.52) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL9248576 | 0.86 | UGT2B7 (0.52) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL954950 | 0.86 | UGT2B7 (0.52) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL954542 | 0.86 | UGT2B7 (0.52) | PTPN2PTPN1UGT2B7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8067644-B2 | Process for conducting an organic reaction in ionic liquids | THE PROCTER & GAMBLE COMPANY (US) | 2011-11-29 | — | — | US | claimed |
| EP-2370387-A2 | PROCESS FOR CONDUCTING AN ORGANIC REACTION IN IONIC LIQUIDS | The Procter & Gamble Company (US) | 2011-10-05 | — | — | EP | claimed |
| US-20110152566-A1 | Process for Conducting an Organic Reaction in Ionic Liquids | THE PROCTER & GAMBLE COMPANY | 2011-06-23 | — | — | US | claimed |
| WO-2010080505-A2 | PROCESS FOR CONDUCTING AN ORGANIC REACTION IN IONIC LIQUIDS | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | claimed |
| US-8067644-B2 | Process for conducting an organic reaction in ionic liquids | THE PROCTER & GAMBLE COMPANY (US) | 2011-11-29 | — | — | US | disclosed |
| EP-2370387-A2 | PROCESS FOR CONDUCTING AN ORGANIC REACTION IN IONIC LIQUIDS | The Procter & Gamble Company (US) | 2011-10-05 | — | — | EP | disclosed |
| US-20110152566-A1 | Process for Conducting an Organic Reaction in Ionic Liquids | THE PROCTER & GAMBLE COMPANY | 2011-06-23 | — | — | US | disclosed |
| WO-2010080505-A2 | PROCESS FOR CONDUCTING AN ORGANIC REACTION IN IONIC LIQUIDS | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152566-A1 | Process for Conducting an Organic Reaction in Ionic Liquids | ACSL3, ACSL1, MCOLN1 | PTPN2 4818/4885PTPN1 4786/4885UGT2B7 3861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.